Recursion Pharmaceuticals, Inc. | ||||
NMS : RXRX || Location: United States | ||||
$7.7+0.1 (+1.32%) |
4.68 M | 7.55 - 7.92 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 39.762 M |
March 15, 2024 | 43.520 M |
Feb. 29, 2024 | 42.816 M |
Feb. 15, 2024 | 38.241 M |
Jan. 31, 2024 | 38.273 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.46 | -0.42 | 8.24% |
09/30/2023 | -0.39 | -0.43 | -9.50% |
06/30/2023 | -0.38 | -0.38 | 0.47% |
03/31/2023 | -0.36 | -0.34 | 4.23% |
12/31/2022 | -0.30 | -0.31 | -4.80% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 227.143M | Shares Float | 188.279M |
Short Float | 39.762M | Market Cap | 1726.29M |
Institution ownership | 92.47% | Insider ownership | 5.653% |
Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
Trailing EPS | -1.58 | Forward EPS | -1.86 |